ExpressCells
company
About
ExpressCells creates custom cell lines for biological research and drug discovery.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $1.20M
- Industries
- Biotechnology,Medical,Product Research
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers.ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.20M
ExpressCells has raised a total of
$1.20M
in funding over 2 rounds. Their latest funding was raised on
Jul 1, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2019 | Series A | $1.20M | 2 |
Keiretsu Forum Mid Atlantic
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
ExpressCells is funded by 2 investors.
Rowan University Venture Fund
and Keiretsu Forum Mid Atlantic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
Keiretsu Forum Mid Atlantic
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
